BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 11514832)

  • 1. Irinotecan and oxaliplatin: an overview of the novel chemotherapeutic options for the treatment of advanced colorectal cancer.
    Grivicich I; Mans DR; Peters GJ; Schwartsmann G
    Braz J Med Biol Res; 2001 Sep; 34(9):1087-103. PubMed ID: 11514832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent experience with oxaliplatin or irinotecan combined with 5-fluorouracil and leucovorin in the treatment of colorectal cancer.
    Kuebler JP; de Gramont A
    Semin Oncol; 2003 Aug; 30(4 Suppl 15):40-6. PubMed ID: 14523794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxaliplatin: a new agent for colorectal cancer.
    Pelley RJ
    Curr Oncol Rep; 2001 Mar; 3(2):147-55. PubMed ID: 11177747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irinotecan or oxaliplatin combined with 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer: a meta-analysis.
    Liang XB; Hou SH; Li YP; Wang LC; Zhang X; Yang J
    Chin Med J (Engl); 2010 Nov; 123(22):3314-8. PubMed ID: 21163137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of irinotecan and oxaliplatin in the treatment of advanced colorectal cancer.
    Khayat D; Gil-Delgado M; Antoine EC; Nizri D; Bastian G
    Oncology (Williston Park); 2001 Apr; 15(4):415-29; discussion 429-30, 433-4. PubMed ID: 11346931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
    Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What's new in ... colorectal cancer. Meaningful progress in therapy options.
    Polansky M; Ross AC
    JAAPA; 2009 Apr; 22(4):51-2. PubMed ID: 19452823
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapy for metastatic colorectal cancer.
    Rosales J; Leong LA
    J Natl Compr Canc Netw; 2005 Jul; 3(4):525-9. PubMed ID: 16038643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of Irinotecan, Oxaliplatin and 5-Fluorouracil as a Rechallenge Regimen for Heavily Pretreated Metastatic Colorectal Cancer Patients.
    Fernandes GDS; Braghiroli MI; Artioli M; Paterlini ACCR; Teixeira MC; Gumz BP; Girardi DDM; Braghiroli OFM; Costa FP; Hoff PM
    J Gastrointest Cancer; 2018 Dec; 49(4):470-475. PubMed ID: 28884286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy of metastatic colorectal cancer.
    Prescrire Int; 2010 Oct; 19(109):219-24. PubMed ID: 21180382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of reintroduction of oxaliplatin for advanced colorectal cancer in patients previously treated with oxaliplatin and irinotecan: RE-OPEN study.
    Suenaga M; Mizunuma N; Matsusaka S; Shinozaki E; Ozaka M; Ogura M; Yamaguchi T
    Drug Des Devel Ther; 2015; 9():3099-108. PubMed ID: 26124634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irinotecan as first-line treatment of colorectal cancer: new indication. A modest advantage.
    Prescrire Int; 2001 Apr; 10(52):41-3. PubMed ID: 11718156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Insight: Metastatic colorectal cancer--oral fluoropyrimidines and new perspectives in the adjuvant setting.
    Folprecht G; Köhne CH
    Nat Clin Pract Oncol; 2005 Nov; 2(11):578-87. PubMed ID: 16270098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The new chemotherapy of colorectal cancers].
    Taïeb J; Boige V; Ducreux M
    Presse Med; 2002 Jan; 31(3):132-8. PubMed ID: 11859739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy: How useful is adjuvant irinotecan in stage IV CRC?
    Loupakis F; Falcone A
    Nat Rev Clin Oncol; 2010 Apr; 7(4):190-1. PubMed ID: 20354542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic advances in the management of metastatic colorectal cancer.
    Freyer G; Ligneau B; Kraft D; Descos L; Trillet-Lenoir V
    Expert Rev Anticancer Ther; 2001 Aug; 1(2):236-46. PubMed ID: 12113029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which drug combination for colorectal cancer?
    Doggrell SA
    Expert Opin Pharmacother; 2004 Dec; 5(12):2621-4. PubMed ID: 15571479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irinotecan plus 5-FU and leucovorin in advanced colorectal cancer: North American trials.
    Goldberg RM; Erlichman C
    Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):59-63. PubMed ID: 9726093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel chemotherapeutic agents in colorectal cancer.
    Napier MP; Ledermann JA
    Eur J Surg Oncol; 2000 Sep; 26(6):605-10. PubMed ID: 11034814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current approaches to first-line treatment of advanced colorectal cancer.
    Goldberg RM
    Clin Colorectal Cancer; 2004 Jun; 4 Suppl 1():S9-15. PubMed ID: 15212700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.